More aggressive marketing ∝ 1/benefit-to-harm ratio

New “Law” Attempts to Explain Strategies Drug Marketers Use to Sway Prescribing, March 16, 2011, Mitka 305 (11): 1083 — JAMA An interesting and concise new article on the influence of marketing on prescribing patterns was published online in the American Journal of Public Health and then picked up in the commentary of JAMA. It … Continue reading More aggressive marketing ∝ 1/benefit-to-harm ratio

PLoS Medicine becomes more interested in research translation

PLoS Medicine: WHO/PLoS Collection “No Health Without Research”: A Call for Papers This is particularly good news for those of us interested in the translation of evidence into practice in medicine. Some of the discussions that PLoS Medicine have listed as desirable include issues around ethics in research, and models of research network organisation.